Target Healthcare REIT (THRL) Share Price, News & Analysis

Company Overview

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

Key Stats

• Today's Range: 105 to 107.60
• 50-Day Range: 102.40 to 109.20
• 52-Week Range: 92 to 111
• Volume: 955,545 shs
• Average Volume: 4.59 million shs
• Market Capitalization: £658.69 million
• P/E Ratio: 8.45
• Dividend Yield: 5.55%
• Price Target: GBX 101
• Consensus Rating: Hold

Target Healthcare REIT Stock Analysis - MarketRank™

Target Healthcare REIT scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

Target Healthcare REIT has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Upside/Downside

The consensus price target for Target Healthcare REIT is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Target Healthcare REIT has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Target Healthcare REIT is 8.45, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.93.

Price to Earnings Ratio vs. Sector

The P/E ratio of Target Healthcare REIT is 8.45, which means that it is trading at a less expensive P/E ratio than the Real Estate sector average P/E ratio of about 29.65.

Price to Earnings Growth Ratio

Target Healthcare REIT has a PEG Ratio of 1.48. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Target Healthcare REIT has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for THRL.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Target Healthcare REIT is a leading dividend payer. It pays a dividend yield of 5.55%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Target Healthcare REIT does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Target Healthcare REIT is 47.10%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

MarketBeat Follows

Only 1 people have added Target Healthcare REIT to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Target Healthcare REIT insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.03% of the stock of Target Healthcare REIT is held by insiders.

Percentage Held by Institutions

48.59% of the stock of Target Healthcare REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 3/18/2026
• Today: 6/18/2026

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Real Estate
• Industry: REIT - Healthcare Facilities
• Sub-Industry: N/A
• Current Symbol: LON:THRL
• CIK: N/A
• Web: www.targethealthcarereit.co.uk
• Phone: +44-131-6252951
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Target Healthcare REIT: GBX 101
• High Price Target: GBX 101
• Low Price Target: GBX 101
• Potential Upside/Downside: -4.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 12.57
• Trailing P/E Ratio: 8.45
• Forward P/E Ratio: 17.07
• P/E Growth: 1.48
• Net Income: £72.07 million
• Net Margins: 104.45%
• Pretax Margin: N/A
• Return on Equity: 10.73%
• Return on Assets: 3.86%

Debt

• Debt-to-Equity Ratio: 27.14
• Current Ratio: N/A
• Quick Ratio: 1.52

Sales & Book Value

• Annual Sales: £83.69 million
• Price / Sales: 7.87
• Cash Flow: GBX 7.39 per share
• Price / Cash Flow: 14.37
• Book Value: GBX 111.13 per share
• Price / Book: 0.96

Miscellaneous

• Outstanding Shares: 620,237,000
• Free Float: N/A
• Market Cap: £658.69 million
• Optionable: Not Optionable
• Beta: 0.69